Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading investment firm focused on the healthcare sector. With over $2 billion under management, they provide growth capital to healthcare companies, investing across various stages and strategies including venture capital, growth buyouts, and leveraged recapitalizations. The firm actively supports portfolio companies with deep domain expertise and industry connections.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Macau
SanReno Therapeutics
Funding Round in 2021
SanReno Therapeutics is a biotechnology company that specializes in the development, manufacturing, and commercialization of therapies for kidney diseases and related conditions. Operating primarily in the People’s Republic of China, Hong Kong, Macau, Taiwan, and Singapore, the company is dedicated to advancing research and development in this therapeutic area. Formed as a joint venture between Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, SanReno Therapeutics aims to create innovative solutions that enhance the quality of life for patients suffering from kidney-related ailments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.